Dr Mark Vanderpump  
Consultant Physician

Medico-legal CV

Dr Mark Patrick John VANDERPUMP MD FRCP
Consultant Physician/Honorary Senior Lecturer in Diabetes and Endocrinology

Address

Department of Endocrinology
Royal Free Hampstead NHS Trust
Pond Street London NW3 2QG
Email: mark.vanderpump@royalfree.nhs.uk
Tel: 020 7472 6280
Fax: 020 7472 6487

Private Secretary Samantha Mulligan
email: samantha@kentmedical.co.uk
Tel:  020 3283 8932
Fax: 01622 620921

Date of Birth

30 December 1963

Qualifications

MBChB (Birm) 1987 MRCP (UK) 1990 MD (Birm) 1995
CCST General Medicine, Diabetes and Endocrinology 1996
FRCP (London) 2001

GMC Registration Number: 3181931
MDU Membership Number: 219076F

Areas of Special Interest

Thyroid disorders
Diabetes mellitus
Pituitary disorders

Selected Publications

Vanderpump MPJ, Ahlquist JAO, Franklyn JA & Clayton RN on behalf of a Working Group of the Research Unit of the Royal College of Physicians and the Endocrinology and Diabetes Committee of the College and Society for Endocrinology (1996). Development of Consensus for Good Practice and Audit Measures in the Management of Hypothyroidism and Hyperthyroidism. British Medical Journal, 313, 539-44.

Vanderpump MPJ & Tunbridge WMG (2002). Epidemiology of Thyroid Disease and Swelling. In "The Thyroid", chapter ed. WM Wiersinga for "Oxford Textbook of Endocrinology" (Ed. JAH Wass and SM Shalet). Oxford University Press, pp 339-349.

Vanderpump MPJ (2003). Subclinical Hypothyroidism - The Case Against Treatment. Trends in Endocrinology and Metabolism, 14, 262-266.

Vanderpump MPJ (2004). Epidemiology of Thyroid Diseases. In "Encyclopedia of Endocrinology and Endocrine Diseases" (Ed. L Martino and Assc. Ed. W Wiersinga). Elsevier Academic Press, Oxford, Vol 4, 401-408.

Vanderpump MPJ (2005). The Epidemiology of Thyroid Diseases. In "Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text", 9/E. (Ed.LE Braverman and RD Utiger). JB Lippincott-Raven, Philadelphia, pp 398-406.

Vanderpump MPJ (2005). What to do with Thyroid Nodules and Goitres. In "Horizons in Medicine 16" (Ed. JA Franklyn). Royal College of Physicians, London, pp 55-62.

Vanderpump MPJ (2007). Invited editorial: Cardiovascular and cancer mortality after radioiodine in hyperthyroidism.  Journal of Clinical Endocrinology and Metabolism, 92,2033-2035.

Smellie WSA, Vanderpump MPJ, Fraser WD, Bowlees R &Shaw N (2008). Best practice in primary care pathology: Review 11 Thyroid teseting, hypercalcaemia and hypocalcaemia. Journal of Clinical Pathology, 61, 410-418.

Vanderpump MPJ (2008).  Is thyroid autoimmunity associated with malignancy? Nature Clinical Practice Endocrinology and Metabolism, 4, 196-197.

Vanderpump MPJ & Tunbridge WMG (2008). Thyroid Disease. The Facts. 4th edition. Oxford University Press.

Other Experience

Clinical Director Medical Specialties Royal Free Hampstead NHS Trust 2004-2006.

Expert Professional Advisor for NHS Ombudsman 2003-2004.

From 2003-2006, I served on a national sub-committee of the British Thyroid Association, Association of Clinical Biochemists and British Thyroid Foundation to produce national guidelines for thyroid function tests.

I regularly referee for papers on thyroid and endocrine disorders for Journal of the American Medical Association, Clinical Endocrinology, Clinical Science, Journal of the Royal Society of Medicine, Journal of Clinical Endocrinology and Metabolism and Journal of Paediatric Endocrinology and Metabolism.
I have been on the editorial board of Clinical Endocrinology from January 2005 and of Journal of Clinical Endocrinology and Metabolism from January 2006.

Membership of Societies

British Thyroid Association: Assistant Secretary from March 2001-March 2002; Secretary from March 2002-March 2005; Executive Member March 2005 to date.

Royal College of Physicians (London)

Society for Endocrinology: Member of Programme Organising Committee for BES 2003-2005 and BES Liaison Committee Member from 2001-2004. I plan the content and chair sessions for British Endocrine Societies national meetings.

BES Liaison Comittee Member from 2001-2004

The American Endocrine Society

American Thyroid Association

Diabetes UK

Association of British Clinical Diabetologists

Medico-Legal Courses Attended

Report Writing for Expert Witness (Bond Solon) 2006
Witness Familiarisation (Bond Solon) 2006

Terms and Conditions

My current terms of engagement are:

My current hourly fee rate is £250 for all time spent on the case.  Itemised billing and copies of receipts will be provided if requested.

Draft report produced within 2-6 weeks (dependent on complexity)
Report for court two weeks following return of draft.

In legally aided cases (where my fees constitute a disbursement), I expect you to make a prompt claim to the Legal Services Commission, and to advise me of any expected delay in settlement. In all other cases I expect payment within 30 days of invoice date from you my Client, irrespective of whether your client has paid you.

Should accounts not be settled within the agreed period, at my discretion, I have the right to charge interest on unpaid accounts at the rate of 2% a month, or part of a month, until full settlement is received.

I am not prepared to have my accounts subjected to assessment and look to you, my Client, to fund my assessment deducted relating to the Case, at any time.

I will use my experience, care and skill in fulfilling your instructions to the best of my ability. Please remember that I am an independent witness.

Please let me have your full instructions, together with any further relevant information you may have, and confirm your agreement in writing to the above terms. Please keep me closely informed on the progress of the case. I can probably help in the period before trial, if indeed the matter proceeds to that stage.